Company’s first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMS and APIs
Dear colleagues, friends, and supporters: As we approach 2024, we want to take a moment to look back over an absolutely astounding year of progress for our business and give thanks to the many who made it possible. Nearly a decade of hard work culminated in an industry-first achievement here at Antheia. In August, we […]
As the Head of Downstream Processing, Suzanne Sato leverages her 19 years of experience to lead downstream chemistry processes at Antheia. Her ability to keep the big picture in focus while working collaboratively with various teams is central to the success of Antheia’s mission. Suzy recently sat down for a Q&A in which she shares […]
Antheia recently joined some of the industry’s most notable thought leaders at the prestigious Forbes Sustainability Leaders Summit, which gathered on September 20 in New York City to discuss insights, innovations, and visions for a more sustainable future. Antheia CEO and co-founder Dr. Christina Smolke had the honor of participating in a panel discussion that […]
On Thursday, the company announced it has completed its first commercial-scale fermentation run, which resulted in the production of 116,000liters of thebaine, a key ingredient for several essential drugs. And rather than a turn around time of a few months, Antheia made the chemical in about five days.
He-Man serves as Antheia’s Chief Dog Officer (CDO), where he has worked diligently to make a paw-sitive impact on employee morale, team dynamics, and the company treat budget. In this blog, He-Man shares more about his exciting life at Antheia and his invaluable role in boosting morale. From Humble Biotech Beginnings to Biomanufacturing Brilliance Before […]
Antheia’s Chief Operations Officer Zack McGahey offers his perspective on the company’s most recent commercial milestone – a successful full-scale fermentation run of its first product at 116,000L.
As the newly appointed Senior Vice President of Commercialization, Richard Sherwin is poised to move Antheia into its next phase by building a vibrant commercial market footprint. His collaborative work with Antheia has spanned nearly a year as a fractional, valued member of the team, and as of August 2023, he’s now full time in preparation for what will be a milestone year in Antheia’s history.
Sherwin to lead Antheia’s global sales strategy for KSM and API products Menlo Park, CA – August 17, 2023 – Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced the appointment of industry veteran, Richard Sherwin as SVP of Commercialization. Sherwin’s hiring comes at a critical juncture in Antheia’s growth trajectory as […]